Vote Scores
Filings read through

CRISPR THERAPEUTICS AG: how funds voted at the meeting of 4 Jun 2026

Ticker
CRSP
Meeting
Season
year to 30 June 2026
Filers reporting
625
Ballot items
7

625 filers on Form N-PX reported votes at the CRISPR THERAPEUTICS AG meeting of 4 Jun 2026. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    12 nominees. 76.6% of the reported votes are for. 89 filers withheld from or voted against at least one nominee.

    3,235 vote records from 117 filers. 14 of the 109 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 39 fund families
    • For 31
    • Against 7
    • Split or no vote 1
    • Against management 6
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,343 vote records from 622 filers. 264 of the 575 filers that marked the item voted against management. 47 filers gave no management mark.

    • Positions of 46 fund families
    • For 16
    • Against 29
    • Split or no vote 1
    • Against management 29
  3. Item 3: Audit-related items (auditor ratification)

    243 vote records from 115 filers. 1 of the 107 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 39 fund families
    • For 38
    • Split or no vote 1
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    667 vote records from 115 filers. 0 of the 107 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 39 fund families
    • For 38
    • Split or no vote 1
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,641 vote records from 124 filers. 35 of the 114 filers that marked the item voted against management. 10 filers gave no management mark.

    • Positions of 39 fund families
    • For 22
    • Against 16
    • Split or no vote 1
    • Against management 16
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,189 vote records from 116 filers. 3 of the 108 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 39 fund families
    • For 37
    • Against 1
    • Split or no vote 1
    • Against management 1
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    65 vote records from 19 filers. 0 of the 18 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 3 fund families
    • For 1
    • Split or no vote 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at CRISPR THERAPEUTICS AG, meeting of 4 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
AllspringAgainst, against managementFor
American BeaconForFor
American CenturyForFor
BairdAgainst, against managementNo report
BlackRock and iSharesForFor
BNY MellonForNo report
Brighthouse FundsForFor
Capital Group and American FundsAgainst, against managementFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementFor
DWSAgainst, against managementFor
EquitableAgainst, against managementFor
Federated HermesAgainst, against managementNo report
FidelityAgainst, against managementFor
First TrustAgainst, against managementNo report
Franklin TempletonAgainst, against managementFor
Global XAgainst, against managementFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
Lord AbbettForNo report
MassMutualForFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementFor
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesAgainst, against managementFor
Nuveen and TIAAAgainst, against managementFor
Pacific Life fundsForFor
PGIM and PrudentialAgainst, against managementFor
PIMCOAgainst, against managementFor
PrincipalSplitSplit
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementFor
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceForFor
VanguardForFor
VoyaForFor
WisdomTreeForFor

Questions

How many filers reported votes at the CRISPR THERAPEUTICS AG meeting?
625 Form N-PX filers reported votes at the meeting of 4 Jun 2026. On say-on-pay, 264 of 575 filers that marked the item voted against management (45.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. CRISPR THERAPEUTICS AG reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list CRISPR THERAPEUTICS AG with a meeting date within three days of 4 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .